Gary W. Pace, Director at Pacira BioSciences, Inc. (PCRX), sold 10,030 shares at $41.78 ($419K) on 2023-05-11, disclosed to the SEC on 2023-05-15.
Open-market sale of $419k PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.78 | 5,015 | $210K | 50.0% |
| 2 | $41.78 | 5,015 | $210K | 50.0% |
| Total | $41.78 avg | 10,030 | $419K | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |